Page last updated: 2024-08-23

etoposide and ic 87114

etoposide has been researched along with ic 87114 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Billottet, C; Gale, RE; Grandage, VL; Khwaja, A; Quattropani, A; Rommel, C; Vanhaesebroeck, B	1

Other Studies

1 other study(ies) available for etoposide and ic 87114

Article	Year
A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. Oncogene, 2006, Oct-26, Volume: 25, Issue:50 Topics: Adenine; Apoptosis; Cell Proliferation; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; Enzyme Activation; Etoposide; Humans; In Vitro Techniques; Leukemia, Myeloid, Acute; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Isoforms; Quinazolines	2006

Article

Year

A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16.

Oncogene, 2006, Oct-26, Volume: 25, Issue:50

Topics: Adenine; Apoptosis; Cell Proliferation; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; Enzyme Activation; Etoposide; Humans; In Vitro Techniques; Leukemia, Myeloid, Acute; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Isoforms; Quinazolines

2006